MARZO, TIZIANO
 Distribuzione geografica
Continente #
NA - Nord America 3.467
EU - Europa 2.015
AS - Asia 468
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 5.962
Nazione #
US - Stati Uniti d'America 3.456
RU - Federazione Russa 682
PL - Polonia 517
IT - Italia 312
IE - Irlanda 230
HK - Hong Kong 126
SE - Svezia 121
SG - Singapore 121
CN - Cina 113
JO - Giordania 42
GB - Regno Unito 36
IN - India 35
DE - Germania 26
FI - Finlandia 23
UA - Ucraina 14
BE - Belgio 13
VN - Vietnam 13
ES - Italia 11
CA - Canada 10
CH - Svizzera 10
CI - Costa d'Avorio 9
TR - Turchia 9
FR - Francia 6
BG - Bulgaria 5
NL - Olanda 4
AT - Austria 3
IQ - Iraq 3
JP - Giappone 3
AU - Australia 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EU - Europa 1
KR - Corea 1
LK - Sri Lanka 1
MX - Messico 1
QA - Qatar 1
Totale 5.962
Città #
Santa Clara 524
Warsaw 516
Fairfield 505
Chandler 250
Ashburn 245
Woodbridge 245
Dublin 230
Seattle 208
Houston 188
Cambridge 182
Wilmington 156
Ann Arbor 120
Florence 92
Singapore 90
Lawrence 89
Altamura 87
Hong Kong 78
Princeton 68
New York 54
Beijing 49
Boston 43
Moscow 34
Buffalo 27
Mumbai 27
Medford 24
Shanghai 22
Boardman 16
San Diego 14
Brussels 13
Barcelona 11
Los Angeles 11
Bern 10
Abidjan 9
Dong Ket 9
Kent 9
Serra 8
Toronto 8
Falls Church 7
Jacksonville 7
London 7
Norwalk 7
Yubileyny 7
Pisa 5
Sofia 5
Cagliari 4
Fiesole 4
Hillsboro 4
Messina 4
Munich 4
Poppi 4
Valeggio Sul Mincio 4
Washington 4
Andover 3
Castelliri 3
Clifton 3
Guangzhou 3
Istanbul 3
Laurel 3
New Delhi 3
Phoenix 3
Rome 3
Vienna 3
Arezzo 2
Baghdad 2
Boulder 2
Casarza Ligure 2
Fort Worth 2
Hounslow 2
Jiaxing 2
Kunming 2
Livorno 2
Lucca 2
Milan 2
Nanjing 2
Oiwakeminami 2
Parma 2
Prato 2
Pune 2
Rui'an 2
Strasbourg 2
West Jordan 2
Acton 1
Auburn Hills 1
Bethesda 1
Blue Point 1
Bochum 1
Bogotá 1
Bremen 1
Cagli 1
Calgary 1
Cantagallo 1
Cardiff 1
Catania 1
Cedar Knolls 1
Chiari 1
Frankfurt Am Main 1
Friesland 1
Fuzhou 1
Groningen 1
Huzhou 1
Totale 4.435
Nome #
Iridium(I) Compounds as Prospective Anticancer Agents: Solution Chemistry, Antiproliferative Profiles and Protein Interactions for a Series of Iridium(I) N-Heterocyclic Carbene Complexes 256
FROM CONVENTIONAL TO NOVEL Pt-BASED ANTINEOPLASTIC AGENTS: MECHANISTIC ASPECTS AND BIOLOGICAL EFFECTS 256
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study 246
A first-in-class and a fished out anticancer platinum compound:: Cis -[PtCl2(NH3)2] and cis -[PtI2(NH3)2] compared for their reactivity towards DNA model systems 236
A Fluorescent Silver(I) Carbene Complex with Anticancer Properties: Synthesis, Characterization, and Biological Studies 204
Auranofin, Et3PAuCl, and Et3PAuI Are Highly Cytotoxic on Colorectal Cancer Cells: A Chemical and Biological Study 168
PtI2(DACH), the iodido analogue of oxaliplatin as a candidate for colorectal cancer treatment: chemical and biological features 163
Reactions of model proteins with aurothiomalate, a clinically established gold(I) drug: The comparison with auranofin 158
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer 157
The combined activation of K Ca 3.1 and inhibition of K v 11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells 150
Auranofin and its Analogues Show Potent Antimicrobial Activity Covering Multiresistant Pathogens: Structure-Activity Relationships 140
Chlorido and bromido oxaliplatin analogues as potential agents for CRC treatment: Solution behavior, protein binding and cytotoxicity evaluation 132
Reaction with proteins of a five-coordinate platinum(II) compound 128
Cytotoxic activity and protein binding through an unusual oxidative mechanism by an iridium(I)–NHC complex 127
ESI-MS studies of the reactions of novel platinum(II) complexes containing O,O'-chelated acetylacetonate and sulfur ligands with selected model proteins 124
Elucidating the reactivity of Pt(II) complexes with (O,S) bidentate ligands towards DNA model systems 123
A case of extensive protein platination: The reaction of lysozyme with a Pt(ii)-terpyridine complex 123
Diruthenium Diacetate-Catalyzed Aerobic Oxidation of Hydroxylamines and Improved Chemoselectivity by Immobilization to Lysozyme 118
Cisplatin and its dibromido analogue: a comparison of chemical and biological profiles 118
Arsenoplatin-1 Is a Dual Pharmacophore Anticancer Agent 117
The leading established metal-based drugs: a revisitation of their relevant physico-chemical data 117
Synthesis, characterization and DNA interactions of [Pt3(TPymT)Cl3], the trinuclear platinum(II) complex of the TPymT ligand 117
Drug repositioning: auranofin as a prospective antimicrobial agent for the treatment of severe staphylococcal infections 107
The cisplatin/serum albumin system: A reappraisal 106
Interaction of a gold(i) dicarbene anticancer drug with human telomeric DNA G-quadruplex: solution and computationally aided X-ray diffraction analysis 106
Interactions of the organogold(III) compound Aubipyc with the copper chaperone Atox1: A joint mass spectrometry and circular dichroism investigation 106
Oxaliplatin vs. cisplatin: Competition experiments on their binding to lysozyme 105
Protein Metalation by Anticancer Metallodrugs: A Joint ESI MS and XRD Investigative Strategy 104
Interaction of anticancer Ru(III) complexes with single stranded and duplex DNA model systems 104
Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin 102
Gold(III) complexes with hydroxyquinoline, aminoquinoline and quinoline ligands: Synthesis, cytotoxicity, DNA and protein binding studies 101
The X-ray structure of the complex formed in the reaction between oxaliplatin and lysozyme 88
cis-Pt I2(NH3)2: a reappraisal 87
Peculiar Features in the Crystal Structure of the Adduct Formed betweencis-PtI2(NH3)2and Hen Egg White Lysozyme 87
Synthesis and Mode of Action Studies on Iridium(I)–NHC Anticancer Drug Candidates 85
New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules 83
Interplay of crystallography, Raman microspectroscopy and electrospray mass spectrometry for studying the reaction between ruthenium complexes and proteins 82
Platinum(II) Complexes with O,S Bidentate Ligands: Biophysical Characterization, Antiproliferative Activity, and Crystallographic Evidence of Protein Binding 79
Reactions of Cytotoxic Metallodrugs with Lysozyme in pure DMSO explored through UV-Vis Absorption Spectroscopy and ESI MS 77
Interactions between Anticancertrans-Platinum Compounds and Proteins: Crystal Structures and ESI-MS Spectra of Two Protein Adducts oftrans-(Dimethylamino)(methylamino)dichloridoplatinum(II) 75
Interactions of carboplatin and oxaliplatin with proteins: Insights from X-ray structures and mass spectrometry studies of their ribonuclease A adducts 72
Ruthenium(II) 1,4,7-trithiacyclononane complexes of curcumin and bisdemethoxycurcumin: Synthesis, characterization, and biological activity 72
Unusual Structural Features in the Lysozyme Derivative of the Tetrakis(acetato)chloridodiruthenium(II,III) Complex 70
Mechanistic Insights Into the Anticancer Properties of the Auranofin Analog Au(PEt3)I: A Theoretical and Experimental Study 69
The first step of arsenoplatin-1 aggregation in solution unveiled by solving the crystal structure of its protein adduct 68
On the Different Mode of Action of Au(I)/Ag(I)-NHC Bis-Anthracenyl Complexes Towards Selected Target Biomolecules 66
Synthesis, DNA binding studies, and antiproliferative activity of novel Pt(II)-complexes with an L-alanyl-based ligand 62
Reactions of cisplatin and cis-[PtI2(NH3)2] with molecular models of relevant protein sidechains: A comparative analysis 61
Mechanistic studies on cytotoxic gold compounds 59
In vitro anti-sars-cov-2 activity of selected metal compounds and potential molecular basis for their actions based on computational study 58
A Role for Metal-Based Drugs in Fighting COVID-19 Infection? The Case of Auranofin 55
Reactions of a tetranuclear Pt-thiosemicarbazone complex with model proteins 48
Reactions of Arsenoplatin-1 with Protein Targets: A Combined Experimental and Theoretical Study 48
null 47
null 31
Description of a Non-Canonical AsPt Blue Species Originating from the Aerobic Oxidation of AP-1 in Aqueous Solution 27
Totale 6.075
Categoria #
all - tutte 16.738
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.738


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020897 0 0 0 0 153 145 132 147 126 88 83 23
2020/2021622 47 61 15 71 32 44 30 36 90 116 48 32
2021/2022403 5 25 32 13 28 16 11 48 28 25 52 120
2022/20231.056 101 254 44 77 61 175 144 50 93 7 24 26
2023/2024412 16 32 64 10 21 91 24 95 9 19 13 18
2024/20251.541 86 275 155 380 645 0 0 0 0 0 0 0
Totale 6.075